# A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy

> **NCT07117175** · EARLY_PHASE1 · NOT_YET_RECRUITING · sponsor: **Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine** · enrollment: 18 (estimated)

## Conditions studied

- Immunology
- Hematologic Malignancies
- CAR-NK

## Interventions

- **DRUG:** Anti-human CD7 CAR-NK cell injection

## Key facts

- **NCT ID:** NCT07117175
- **Lead sponsor:** Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09-01
- **Primary completion:** 2027-12-15
- **Final completion:** 2028-01-30
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2025-08-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07117175

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07117175, "A Clinical Study to Evaluate the Safety and Efficacy of Anti-human CD 7 CAR-NK Cell Injection in Subjects With Relapsed and Refractory CD7-positive Hematological Malignancy". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07117175. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*